ViaCyte (fka Novocell)

Novel cell replacement therapies as potential long-term diabetes treatments to reduce the risk of hypoglycemia and diabetes-related complications.

Get a Demo and See the Full Profile

Get a demo today to see profiles of ViaCyte (fka Novocell) plus 6038 other startups.

Learn More About ViaCyte (fka Novocell)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups

More